NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)TO ENSURE THAT ALL HIGH QUALITY BIOMEDICAL RESEARCH RESULTS - INCLUDING NEGATIVE AND INCONCLUSIVE RESULTS - ARE ACCESSIBLE TO RESEARCHERS, CLINICIANS AND PATIENTS IN THE INTEREST OF SAFETY AND RESEARCH EFFICIENCY
CONTRACTED WITH COHEN VETERANS BIOSCIENCE AND MARY ANN LIEBERT PUBLISING TO PRODUCE NULL HYPOTHESIS WITHIN THE NEUROTRAUMA REPORTS JOURNAL. BENEFIT OF ENTIRE JOURNAL READERSHIP WAS GREATER THAN 5000...
CONTRACTED WITH COHEN VETERANS BIOSCIENCE AND MARY ANN LIEBERT PUBLISING TO PRODUCE NULL HYPOTHESIS WITHIN THE NEUROTRAUMA REPORTS JOURNAL. BENEFIT OF ENTIRE JOURNAL READERSHIP WAS GREATER THAN 5000 AND BROADER BIOMEDICAL RESEARCH COMMUNITY IN GENERAL AS WELL AS PROVIDED VIRTUAL BIOMEDICAL TRANSPARENCY SUMMIT WEBINAR SERIES TO AN AUDIENCE OF OVER 500
PROVIDED VIRTUAL BIOMEDICAL TRANSPARENCY SUMMIT WEBINAR SERIES TO AN AUDIENCE OF OVER 500
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | N/A | $107,538 | -1.0% |
| Expenses | $4,074 | $208,264 | -1.0% |
| Net Income | N/A | $-100,726 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR SANDRA PETTY | CHIEF MEDICAL OFFICER | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR DIMITRIE HUGO STEPHENSON | CEO | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| ERIC JAFFE | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | $4,074 | $216,610 | No data |
| 2023 | $107,538 | $208,264 | No data | $-100,726 |
| 2022 | $80,000 | $68,299 | $87,866 | $11,701 |
| 2021 | $66,271 | $37,705 | $48,686 | $28,566 |
| 2019 | $124,065 | $134,292 | $133,081 | $-10,227 |
Compare CENTER FOR BIOMEDICAL RESEARCH TRANSPARENCY INC with other nonprofits in New York and across the country.